UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HDL cholesterol and protective factors in atherosclerosis

Circulation (New York, N.Y.), 2004-06, Vol.109 (23 Suppl 1), p.III8-II14

2004

Volltextzugriff (PDF)

Atheroprotective Effects of High-Density Lipoproteins

Annual review of medicine, 2003-01, Vol.54 (1), p.321-341

2003

Volltextzugriff (PDF)

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

The American journal of cardiology, 2008-11, Vol.102 (10), p.1K-34K

2008

Volltextzugriff (PDF)

Harmonizing the Definition of the Metabolic Syndrome: Comparison of the Criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European Populations

The American journal of cardiology, 2007-02, Vol.99 (4), p.541-548

2007

Volltextzugriff (PDF)

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

Arteriosclerosis, thrombosis, and vascular biology, 2008-08, Vol.28 (8), p.1542-1548

2008

Volltextzugriff (PDF)

HDL and arteriosclerosis: beyond reverse cholesterol transport

Atherosclerosis, 2002-03, Vol.161 (1), p.1-16

2002

Volltextzugriff (PDF)

Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM

European heart journal, 2005-10, Vol.26 (20), p.2120-2126

2005

Volltextzugriff (PDF)

Prevalence of cholesteryl ester storage disease

Arteriosclerosis, thrombosis, and vascular biology, 2007-08, Vol.27 (8), p.1866-1868

2007

Volltextzugriff (PDF)

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

Diabetes & vascular disease research, 2008-11, Vol.5 (4), p.319-335

2008

Volltextzugriff (PDF)

Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids

The Journal of biological chemistry, 2001-09, Vol.276 (37), p.34480-34485

2001

Volltextzugriff (PDF)

Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element

Atherosclerosis, 2007-03, Vol.191 (1), p.11-21

2007

Volltextzugriff (PDF)

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

Atherosclerosis, 1996-07, Vol.124, p.S11-S20

1996

Volltextzugriff (PDF)

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)

The American journal of cardiology, 1992-09, Vol.70 (7), p.733-737

1992

Volltextzugriff (PDF)

Effect of the interleukin-6 promoter polymorphism (−174 G/C) on the incidence and outcome of sepsis

Critical care medicine, 2002-01, Vol.30 (1), p.32-37

2002

Volltextzugriff (PDF)

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

Current medical research and opinion, 2010-12, Vol.26 (12), p.2833-2839

2010

Volltextzugriff (PDF)

Risk for Diabetes Mellitus in Middle-Aged Caucasian Male Participants of the PROCAM Study: Implications for the Definition of Impaired Fasting Glucose by the American Diabetes Association

The journal of clinical endocrinology and metabolism, 2000-09, Vol.85 (9), p.3101-3108

2000

Volltextzugriff (PDF)

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders

Atherosclerosis, 2003-05, Vol.168 (1), p.81-89

2003

Volltextzugriff (PDF)

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

Current opinion in lipidology, 2000-12, Vol.11 (6), p.627-637

2000

Volltextzugriff (PDF)

Non-LDL-related dyslipidaemia and coronary risk: a case-control study

Diabetes & vascular disease research, 2010-07, Vol.7 (3), p.204-212

2010

Volltextzugriff (PDF)

Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter

Journal of lipid research, 2006-04, Vol.47 (4), p.794-803

2006

Volltextzugriff (PDF)

Follicular Fluid High Density Lipoprotein-associated Sphingosine 1-Phosphate Is a Novel Mediator of Ovarian Angiogenesis

The Journal of biological chemistry, 2006-03, Vol.281 (9), p.5398-5405

2006

Volltextzugriff (PDF)

Polyunsaturated Fatty Acids and Acetoacetate Downregulate the Expression of the ATP-Binding Cassette Transporter A1

Diabetes (New York, N.Y.), 2002-10, Vol.51 (10), p.2922-2928

2002

Volltextzugriff (PDF)

High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells

Biochemical and biophysical research communications, 2003-10, Vol.310 (1), p.98-103

2003

Volltextzugriff (PDF)

Beyond statin therapy: why we need new thinking

Current medical research and opinion, 2005, Vol.21 (S6), p.S3-S8

Assmann, Gerd

2005

Volltextzugriff (PDF)

Cholesterol absorption inhibitor Ezetimibe blocks uptake of oxidized LDL in human macrophages

Biochemical and biophysical research communications, 2004-08, Vol.320 (4), p.1337-1341

2004

Volltextzugriff (PDF)

1 – 25 von 434

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(342)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(261)
Humans
(256)
Life Sciences & Biomedicine
(254)
Male
(144)
Biological And Medical Sciences
(135)
Cardiovascular System & Cardiology
(107)
Female
(107)
Medical Sciences
(105)
Middle Aged
(97)
Adult
(93)
Cardiac & Cardiovascular Systems
(76)
Risk Factors
(71)
Peripheral Vascular Disease
(67)
Aged
(60)
Animals
(55)
Biochemistry & Molecular Biology
(51)
Cardiology. Vascular System
(50)
Coronary Heart Disease
(43)
Atherosclerosis
(39)
Cholesterol, Hdl - Blood
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HDL cholesterol and protective factors in atherosclerosis

Atheroprotective Effects of High-Density Lipoproteins

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

Harmonizing the Definition of the Metabolic Syndrome: Comparison of the Criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European Populations

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

HDL and arteriosclerosis: beyond reverse cholesterol transport

Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM

Prevalence of cholesteryl ester storage disease

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

Suppression of Endothelial Cell Apoptosis by High Density Lipoproteins (HDL) and HDL-associated Lysosphingolipids

Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)

Effect of the interleukin-6 promoter polymorphism (−174 G/C) on the incidence and outcome of sepsis

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

Risk for Diabetes Mellitus in Middle-Aged Caucasian Male Participants of the PROCAM Study: Implications for the Definition of Impaired Fasting Glucose by the American Diabetes Association

Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

Non-LDL-related dyslipidaemia and coronary risk: a case-control study

Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter

Follicular Fluid High Density Lipoprotein-associated Sphingosine 1-Phosphate Is a Novel Mediator of Ovarian Angiogenesis

Polyunsaturated Fatty Acids and Acetoacetate Downregulate the Expression of the ATP-Binding Cassette Transporter A1

High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells

Beyond statin therapy: why we need new thinking

Cholesterol absorption inhibitor Ezetimibe blocks uptake of oxidized LDL in human macrophages

Suchergebnisse filtern